Survival prognosis evaluation in advanced breast cancer patients: a study on the application of the advanced lung cancer inflammation index

BackgroundInflammation and nutritional status play critical roles in tumor initiation and progression. Advanced Lung Cancer Inflammation Index (ALI) has gained widespread attention as a novel biomarker for cancer prognosis evaluation.MethodsThis retrospective study analyzed 163 advanced breast cance...

Full description

Saved in:
Bibliographic Details
Main Authors: Chunfeng Liang, Chunyan Yang, Qiujiao Yang, Yuchen Tang, Wenhai Zhang, Qixing Tan, Qinghong Qin
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1598069/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849695273392013312
author Chunfeng Liang
Chunyan Yang
Qiujiao Yang
Yuchen Tang
Wenhai Zhang
Qixing Tan
Qinghong Qin
author_facet Chunfeng Liang
Chunyan Yang
Qiujiao Yang
Yuchen Tang
Wenhai Zhang
Qixing Tan
Qinghong Qin
author_sort Chunfeng Liang
collection DOAJ
description BackgroundInflammation and nutritional status play critical roles in tumor initiation and progression. Advanced Lung Cancer Inflammation Index (ALI) has gained widespread attention as a novel biomarker for cancer prognosis evaluation.MethodsThis retrospective study analyzed 163 advanced breast cancer patients with distant metastasis (Guangxi Medical University Cancer Hospital, 2016-2023). Patients were stratified into high-ALI (n=64) and low-ALI (n=99) groups via K-means clustering. Kaplan-Meier survival curves with log-rank testing were used to assess survival differences, while Cox proportional hazards models were employed to evaluate the independent prognostic value of ALI. The predictive performance of ALI was assessed using time-dependent ROC curves.ResultsHigh ALI correlated with superior overall survival (log-rank p=0.0024) [HR=2.493 (95%CI 1.350-4.606) p = 0.004]. Multivariate analysis confirmed ALI as an independent prognostic factor (HR=0.39, 95% CI 0.16-0.95, p=0.037). ALI demonstrated stable predictive accuracy with 3-year AUC=0.645 and 5-year AUC=0.650 (C-index=0.65). Subgroup analyses confirmed prognostic consistency across clinical characteristics (p-interaction>0.05).ConclusionALI is an independent prognostic factor for advanced breast cancer patients with good predictive ability. It provides an important supplementary prognostic marker for clinical practice and can help optimize personalized treatment strategies.
format Article
id doaj-art-5521ca1986274f94b528fe0be91fb429
institution DOAJ
issn 2234-943X
language English
publishDate 2025-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj-art-5521ca1986274f94b528fe0be91fb4292025-08-20T03:19:50ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-06-011510.3389/fonc.2025.15980691598069Survival prognosis evaluation in advanced breast cancer patients: a study on the application of the advanced lung cancer inflammation indexChunfeng LiangChunyan YangQiujiao YangYuchen TangWenhai ZhangQixing TanQinghong QinBackgroundInflammation and nutritional status play critical roles in tumor initiation and progression. Advanced Lung Cancer Inflammation Index (ALI) has gained widespread attention as a novel biomarker for cancer prognosis evaluation.MethodsThis retrospective study analyzed 163 advanced breast cancer patients with distant metastasis (Guangxi Medical University Cancer Hospital, 2016-2023). Patients were stratified into high-ALI (n=64) and low-ALI (n=99) groups via K-means clustering. Kaplan-Meier survival curves with log-rank testing were used to assess survival differences, while Cox proportional hazards models were employed to evaluate the independent prognostic value of ALI. The predictive performance of ALI was assessed using time-dependent ROC curves.ResultsHigh ALI correlated with superior overall survival (log-rank p=0.0024) [HR=2.493 (95%CI 1.350-4.606) p = 0.004]. Multivariate analysis confirmed ALI as an independent prognostic factor (HR=0.39, 95% CI 0.16-0.95, p=0.037). ALI demonstrated stable predictive accuracy with 3-year AUC=0.645 and 5-year AUC=0.650 (C-index=0.65). Subgroup analyses confirmed prognostic consistency across clinical characteristics (p-interaction>0.05).ConclusionALI is an independent prognostic factor for advanced breast cancer patients with good predictive ability. It provides an important supplementary prognostic marker for clinical practice and can help optimize personalized treatment strategies.https://www.frontiersin.org/articles/10.3389/fonc.2025.1598069/fulladvanced breast cancersurvival prognosisadvanced lung cancer inflammation index (ALI)inflammationnutritional status
spellingShingle Chunfeng Liang
Chunyan Yang
Qiujiao Yang
Yuchen Tang
Wenhai Zhang
Qixing Tan
Qinghong Qin
Survival prognosis evaluation in advanced breast cancer patients: a study on the application of the advanced lung cancer inflammation index
Frontiers in Oncology
advanced breast cancer
survival prognosis
advanced lung cancer inflammation index (ALI)
inflammation
nutritional status
title Survival prognosis evaluation in advanced breast cancer patients: a study on the application of the advanced lung cancer inflammation index
title_full Survival prognosis evaluation in advanced breast cancer patients: a study on the application of the advanced lung cancer inflammation index
title_fullStr Survival prognosis evaluation in advanced breast cancer patients: a study on the application of the advanced lung cancer inflammation index
title_full_unstemmed Survival prognosis evaluation in advanced breast cancer patients: a study on the application of the advanced lung cancer inflammation index
title_short Survival prognosis evaluation in advanced breast cancer patients: a study on the application of the advanced lung cancer inflammation index
title_sort survival prognosis evaluation in advanced breast cancer patients a study on the application of the advanced lung cancer inflammation index
topic advanced breast cancer
survival prognosis
advanced lung cancer inflammation index (ALI)
inflammation
nutritional status
url https://www.frontiersin.org/articles/10.3389/fonc.2025.1598069/full
work_keys_str_mv AT chunfengliang survivalprognosisevaluationinadvancedbreastcancerpatientsastudyontheapplicationoftheadvancedlungcancerinflammationindex
AT chunyanyang survivalprognosisevaluationinadvancedbreastcancerpatientsastudyontheapplicationoftheadvancedlungcancerinflammationindex
AT qiujiaoyang survivalprognosisevaluationinadvancedbreastcancerpatientsastudyontheapplicationoftheadvancedlungcancerinflammationindex
AT yuchentang survivalprognosisevaluationinadvancedbreastcancerpatientsastudyontheapplicationoftheadvancedlungcancerinflammationindex
AT wenhaizhang survivalprognosisevaluationinadvancedbreastcancerpatientsastudyontheapplicationoftheadvancedlungcancerinflammationindex
AT qixingtan survivalprognosisevaluationinadvancedbreastcancerpatientsastudyontheapplicationoftheadvancedlungcancerinflammationindex
AT qinghongqin survivalprognosisevaluationinadvancedbreastcancerpatientsastudyontheapplicationoftheadvancedlungcancerinflammationindex